A recent randomized controlled trial evaluated the long-term effects of Provox Life heat and moisture exchangers (HMEs) in laryngectomy patients who had never previously used an HME, providing new evidence on pulmonary health and patient-reported outcomes over a nine-month period.
What this study evaluated
The study included 79 patients, and 66 completed the study after nine months. Participants were randomized to either begin using Provox Life HMEs or continue without HME use (standard care). The objective was to assess the long-term effects of Provox Life HME use on pulmonary symptoms and related patient outcomes. The study is notable for being the first long-term randomized controlled trial evaluating Provox Life HMEs in HME-naïve patients.
Does HME use improve pulmonary health and mucus management?
Pulmonary health was assessed using the CASA-Q questionnaire, with cough symptoms being the primary endpoint. Clinically meaningful and statistically significant improvements were observed across all four CASA-Q domains among patients using Provox Life HMEs, while outcomes remained largely unchanged in the control group.
The study also found significantly lower levels of forced mucus expectorations among patients using Provox Life HMEs. Reductions were observed throughout the study period, and dried mucus or crusting around the stoma also decreased significantly. Participants also reported less frequent stoma cleaning over time.
How does HME use affect sleep and quality of life?
Sleep quality improved significantly among participants using Provox Life HMEs during the nine-month study period. Researchers observed improvements in sleep scores as well as reductions in frequent nighttime awakenings. Comparable improvements were not observed in the control group.
Improvements in pulmonary symptoms and sleep quality were accompanied by positive trends in overall health-related quality of life among patients using Provox Life. While individual quality-of-life domains did not show significant differences within or between groups, overall quality-of-life index improved over time in the Provox Life group.
Can HME-naïve patients successfully adapt to HME use?
One of the study's notable findings was the high level of adherence to HME use. Already at the first follow-up after three months, mean daily HME use in the Provox Life group was 23.5 hours. By the final follow-up, participants in the Provox Life group were using HMEs for an average of 23.9 hours per day, indicating near-continuous use. Nighttime use was also consistently high throughout the study.
Patient satisfaction was similarly positive. Participants reported improvements in areas such as coughing, mucus management, sleep quality, stoma hygiene, and droplet management. Nearly 90% rated their overall experience as very good, and most reported no barriers to continued long-term use.
What these findings may mean for laryngectomy care
The study demonstrates that near-continuous HME use can be successfully established in patients who previously did not use HMEs. Over nine months, improvements were observed in pulmonary health, mucus management, sleep quality, quality of life, and patient satisfaction. Together, these findings contribute to the growing body of evidence supporting the role of Provox Life HMEs in long-term laryngectomy care.
Stay up to date with the latest clinical evidence, research, and educational resources in laryngectomy and tracheostomy care. Subscribe to our clinical newsletter.